Search
Results: 8
Recommendations for monitoring and reporting harm in mindfulness for psychosis research
There is increasing interest in potential harmful effects of mindfulness-based interventions. In relation to psychosis, inconsistency and shortcomings in how harm is monitored and reported are holding back our understanding....
Monthly high-dose vitamin D3 supplementation and self-reported adverse events in a 4-year randomized controlled trial.
Zarintaj Malihi, Carlene MM Lawes, Zhenqiang Wu, Ying Huang, Debbie Waayer, L Toop, Kay-Tee Khaw, Carlos A Camargo, Robert Scragg
Sep 20, 2018
Recommendations for monitoring and reporting harm in mindfulness for psychosis research
There is increasing interest in potential harmful effects of mindfulness-based interventions. In relation to psychosis, inconsistency and shortcomings in how harm is monitored and reported are holding back our understanding....
Integrated safety profile of atacicept
Caroline Gordon, Roberto Bassi, Peter Chang, Amy Kao, David Jayne, David Wofsy, Patricia Fleuranceau-Morel
Jan 17, 2020
OBJECTIVE: To characterize the overall safety profile of atacicept, we conducted an integrated analysis of pooled safety data from all 17 clinical studies to date. METHODS: Three data sets were used to investigate safety...
Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease
Hajira Dambha-Miller, Ali Albasri, Sam Hodgson, Christopher R Wilcox, Shareen Khan, Nazrul Islam, Paul Little, Simon J Griffin
Sep 16, 2020
Adverse events Public Health respiratory infections Angiotensin Receptor Antagonists Angiotensin-Converting Enzyme 2 Angiotensin-Converting Enzyme Inhibitors Anti-Inflammatory Agents Non-Steroidal Betacoronavirus covid-19 Calcium Channel Blockers Coronavirus Infections Down-Regulation Estrogens Glucagon-Like Peptide 1 Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors Hypoglycemic Agents Insulin Mineralocorticoid Receptor Antagonists Pandemics Peptidyl-Dipeptidase A Pneumonia Viral SARS-CoV-2 Thiazolidinediones United Kingdom Up-Regulation
Metabolic adverse events associated with systemic corticosteroid therapy-a systematic review and meta-analysis.
Spoorthy Kulkarni, Hannah Durham, Luke Glover, Osaid Ather, Veronica Phillips, Szilard Nemes, Leslie Cousens, Parmis Blomgran, Philip Ambery
Jan 24, 2023
OBJECTIVES: To assess the risk of new-onset or worsening hyperglycaemia, hypertension, weight gain and hyperlipidaemia with systemic corticosteroid therapy (CST) as reported in published randomised control trial (RCT) studies....